PCPDTBT, a marginally crystallizable polymer, is crystallized into a new crystal structure using solvent‐vapor annealing. Highly ordered areas with three different polymer‐chain orientations are ...identified using TEM/ED, GIWAXS, and polarized Raman spectroscopy. The optical and structural properties differ significantly from films prepared by standard device preparation protocols. Bilayer solar cells, however, show similar performance.
We highlight the influence of processing conditions on polymorphism and structure formation on the mesoscale for the family of PCPDTBT polymers with branched alkyl side chains. Direct correlations of ...morphology to the chemical structure and to transistor device performance are established. We found that up to four different packing motifs could be realized depending on the polymer derivative and the processing conditions: amorphous, π-stacked, cross-hatched and dimer-containing polymorphs. While C- and F-PCPDTBT display similar packing behavior organizing in π-stacked and dimer-like structures, Si-PCPDTBT gives rise to cross-hatched structures upon simple deposition from solution. The observed differences in chain packing for C-/F-PCPDTBT versus Si-PCPDTBT are attributed to differences in backbone conformations and aggregation behavior in solution. The effect of polymorphism on charge transport is probed using field-effect transistors, in which both π-stacked and cross-hatched polymer chain arrangements yield the highest hole mobilities. Mesoscopic morphology and mobility simulations rationalize our experimental findings by relating mobility to distributions of electronic coupling elements between the chains.
We present a systematic study of the morphology and absorption properties of a typical donor–acceptor polymer (PCPDTBT) with semicrystalline behavior in solution and in thin films. In-situ ...spectroelectrochemical data give information about the evolution of the absorption spectra from neutral to charged species. The experimental data are supported by theoretical calculations in the framework of the density functional theory (DFT). Regarding thin film structures, we show that the choice of the solvent has significant influence on the morphology in thin films: whereas CS2 and CHCl3 give rather structureless (amorphous) morphologies, films from 1-CN exhibit a clear crystalline nanofiber morphology. Accompanying UV/vis/NIR spectra of films are highly dependent on the morphology and therefore on the choice of the processing solvent. The absorption of fiber morphologies is strongly red-shifted compared to the structureless films.
Summary Background Preoperative chemoradiotherapy, total mesorectal excision surgery, and adjuvant chemotherapy with fluorouracil is the standard combined modality treatment for rectal cancer. With ...the aim of improving disease-free survival (DFS), this phase 3 study (CAO/ARO/AIO-04) integrated oxaliplatin into standard treatment. Methods This was a multicentre, open-label, randomised, phase 3 study in patients with histologically proven carcinoma of the rectum with clinically staged T3–4 or any node-positive disease. Between July 25, 2006, and Feb 26, 2010, patients were randomly assigned to two groups: a control group receiving standard fluorouracil-based combined modality treatment, consisting of preoperative radiotherapy of 50·4 Gy plus infusional fluorouracil (1000 mg/m2 days 1–5 and 29–33), followed by surgery and four cycles of bolus fluorouracil (500 mg/m2 days 1–5 and 29; fluorouracil group); and an experimental group receiving preoperative radiotherapy of 50·4 Gy plus infusional fluorouracil (250 mg/m2 days 1–14 and 22–35) and oxaliplatin (50 mg/m2 days 1, 8, 22, and 29), followed by surgery and eight cycles of adjuvant chemotherapy with oxaliplatin (100 mg/m2 days 1 and 15), leucovorin (400 mg/m2 days 1 and 15), and infusional fluorouracil (2400 mg/m2 days 1–2 and 15–16; fluorouracil plus oxaliplatin group). Randomisation was done with computer-generated block-randomisation codes stratified by centre, clinical T category (cT1–4 vs cT4), and clinical N category (cN0 vs cN1–2) without masking. DFS is the primary endpoint. Secondary endpoints, including toxicity, compliance, and histopathological response are reported here. Safety and compliance analyses included patients as treated, efficacy endpoints were analysed according to the intention-to-treat principle. This study is registered with ClinicalTrials.gov , number NCT00349076. Findings Of the 1265 patients initially enrolled, 1236 were evaluable (613 in the fluorouracil plus oxaliplatin group and 623 in the fluorouracil group). Preoperative grade 3–4 toxic effects occurred in 140 (23%) of 606 patients who actually received fluorouracil and oxaliplatin during chemoradiotherapy and in 127 (20%) of 624 patients who actually received fluorouracil chemoradiotherapy. Grade 3–4 diarrhoea was more common in those who received fluorouracil and oxaliplatin during chemoradiotherapy than in those who received fluorouracil during chemoradiotherapy (73 patients 12% vs 52 patients 8%), as was grade 3–4 nausea or vomiting (23 4% vs nine 1%). 516 (85%) of the 606 patients who received fluorouracil and oxaliplatin-based chemoradiotherapy had the full dose of chemotherapy, and 571 (94%) had the full dose of radiotherapy; as did 495 (79%) and 601 (96%) of 624 patients who received fluorouracil-based chemoradiotherapy, respectively. A pathological complete response was achieved in 103 (17%) of 591 patients who underwent surgery in the fluorouracil and oxaliplatin group and in 81 (13%) of 606 patients who underwent surgery in the fluorouracil group (odds ratio 1·40, 95% CI 1·02–1·92; p=0·038). In the fluorouracil and oxaliplatin group, 352 (81%) of 435 patients who began adjuvant chemotherapy completed all cycles (with or without dose reduction), as did 386 (83%) of 463 patients in the fluorouracil group. Interpretation Inclusion of oxaliplatin into modified fluorouracil-based combined modality treatment was feasible and led to more patients achieving a pathological complete response than did standard treatment. Longer follow-up is needed to assess DFS. Funding German Cancer Aid (Deutsche Krebshilfe).
Multiplicities of charged hadrons produced in deep inelastic muon scattering off a
6
LiD target have been measured as a function of the DIS variables
x
Bj
,
Q
2
,
W
2
and the final state hadron ...variables
p
T
and
z
. The
distributions are fitted with a single exponential function at low values of
to determine the dependence of
on
x
Bj
,
Q
2
,
W
2
and
z
. The
z
-dependence of
is shown to be a potential tool to extract the average intrinsic transverse momentum squared of partons,
, as a function of
x
Bj
and
Q
2
in a leading order QCD parton model.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
Using a novel analysis technique, the gluon polarisation in the nucleon is re-evaluated using the longitudinal double-spin asymmetry measured in the cross section of semi-inclusive single-hadron ...muoproduction with photon virtuality
Q
2
>
1
(
GeV
/
c
)
2
. The data were obtained by the COMPASS experiment at CERN using a 160 GeV/
c
polarised muon beam impinging on a polarised
6
LiD target. By analysing the full range in hadron transverse momentum
p
T
, the different
p
T
-dependences of the underlying processes are separated using a neural-network approach. In the absence of pQCD calculations at next-to-leading order in the selected kinematic domain, the gluon polarisation
Δ
g
/
g
is evaluated at leading order in pQCD at a hard scale of
μ
2
=
⟨
Q
2
⟩
=
3
(
GeV
/
c
)
2
. It is determined in three intervals of the nucleon momentum fraction carried by gluons,
x
g
, covering the range
0.04
<
x
g
<
0.28
and does not exhibit a significant dependence on
x
g
. The average over the three intervals,
⟨
Δ
g
/
g
⟩
=
0.113
±
0
.
038
(
stat
.
)
±
0
.
036
(
syst
.
)
at
⟨
x
g
⟩
≈
0.10
, suggests that the gluon polarisation is positive in the measured
x
g
range.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
We present a new amplitude analysis of the eta pi D-wave in the reaction pi(-) p -> eta pi(-) p measured by COMPASS. Employing an analytical model based on the principles of the relativistic ...S-matrix, we find two resonances that can be identified with the a(2)(1320) and the excited a(2)(1700), and perform a comprehensive analysis of their pole positions. For the mass and width of the a(2) we find M = (1307 +/- 1 6) MeV and Gamma=(112 +/- 1 +/- 8) MeV, and for the excited state a(2)' we obtain M = (1720 +/- 10 +/- 60) MeV and Gamma = (280 +/- 10 +/- 70) MeV, respectively.
(Abstracted from Lancet 2016;388:1775–1812)Seventeen Sustainable Development Goals (SDGs) were adopted by the global community to provide benchmark targets for global development between 2015 and ...2030 and to reframe the Millennium Development Goals (MDGs) to achieve sustainable global development. This report presents data on maternal mortality in 195 countries from 1990 to 2015.
(ProQuest: ... denotes formulae and/or non-USASCII text omitted; see image).Large samples of Lambda , capital sigma (1385) and Xi (1321) hyperons produced in the deep-inelastic muon scattering off a ...super(6)LiD target were collected with the COMPASS experimental setup at CERN. The relative yields of capital sigma (1385) super(+), capital sigma (1385) super(-), ..., ..., Xi (1321) super(-), and ... hyperons decaying into ... were measured. The ratios of heavy-hyperon to Lambda and heavy-antihyperon to ... were found to be in the range 3.8 % to 5.6 % with a relative uncertainty of about 10 %. They were used to tune the parameters relevant for strange particle production of the LEPTO Monte Carlo generator.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
PDF
